1. Trial Watch: Peptide-based anticancer vaccines
   Jonathan Pol et al, 2015, OncoImmunology CrossRef
2. Current Status and Future Prospects of Peptide-Based Cancer vaccines
   Satoshi Wada et al, 2016, Immunotherapy CrossRef
3. Current Status of Immunotherapy Treatments for Pancreatic Cancer
   Cristina Jimenez-Luna et al, 2016, Journal of Clinical Gastroenterology CrossRef
4. Trials of vaccines for pancreatic ductal adenocarcinoma: Is there any hope of an improved prognosis?
   Toru Mizuguchi et al, 2016, Surgery Today CrossRef
5. Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccination
   Shinjiro Sakamoto et al, 2015, Human Vaccines & Immunotherapeutics CrossRef
6. An update on treatment options for pancreatic adenocarcinoma
   Aurélien Lambert et al, 2019, Therapeutic Advances in Medical Oncology CrossRef
7. Integrity of plasma DNA is inversely correlated with vaccine-induced antitumor immunity in ovarian cancer patients
   Kayoko Waki et al, 2020, Cancer Immunology, Immunotherapy CrossRef
8. Personalized Peptide Vaccine for Advanced Pancreatic Cancer
   Shigeru Yutani et al, 2017, Pancreatic Cancer CrossRef
9. Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer
   Shinjiro Sakamoto et al, 2017, Clinical Lung Cancer CrossRef
10. Personalized peptide vaccines for cancer therapy: current progress and state of the art
    Satoshi Wada et al, 2017, Expert Review of Precision Medicine and Drug Development CrossRef
11. Immunological therapy: A novel thriving area for triple-negative breast cancer treatment
    Xiangyu Wang et al, 2019, Cancer Letters CrossRef
12. Progress and challenges of immunotherapy in triple-negative breast cancer
    Yinxing Zhu et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
13. Therapeutic cancer vaccines: From initial findings to prospects
    Qian Song et al, 2018, Immunology Letters CrossRef
14. Complete remission of advanced pancreatic cancer induced by claudin18.2-targeted CAR-T cell therapy: a case report
    Guocheng Zhong et al, 2024, Frontiers in Immunology CrossRef
15. The Next Frontier in Pancreatic Cancer: Targeting the Tumor Immune Milieu and Molecular Pathways
    Chao Yin et al, 2022, Cancers CrossRef
16. Immunotherapy for pancreatic cancer
    Elias Kotteas et al, 2016, Journal of Cancer Research and Clinical Oncology CrossRef
17. Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity
    Coralie M. Backlund et al, 2022, Proceedings of the National Academy of Sciences CrossRef
18. Genomic profiling in pancreatic ductal adenocarcinoma and a pathway towards therapy individualization: A scoping review
    Ritu R. Singh et al, 2019, Cancer Treatment Reviews CrossRef
19. Discrimination of a single nucleotide polymorphism in the haptoglobin promoter region, rs5472, using a competitive fluorophore-labeled probe hybridization assay following loop-mediated isothermal amplification
    Satoru Michiyuki et al, 2021, Bioscience, Biotechnology, and Biochemistry CrossRef
20. Molecular Targeted Intervention for Pancreatic Cancer
    Altaf Mohammed et al, 2015, Cancers CrossRef
21. Synergistic anti‐pancreatic cancer immunological effects by treatment with reduced expression in immortalized cells/dickkopf‐3 protein and peripheral blood mononuclear cells
    Daisuke Uchida et al, 2016, Journal of Gastroenterology and Hepatology CrossRef
22. Improving Outcomes in Pancreatic Cancer
    Reya Sharman et al, 2020, Oncology & Hematology Review (US) CrossRef
23. Pancreatic Cancer and Immunotherapy: A Clinical Overview
    Florentine E. F. Timmer et al, 2021, Cancers CrossRef
24. Prospects for a personalized peptide vaccine against lung cancer
    Yoshiro Nakahara et al, 2019, Expert Review of Vaccines CrossRef
25. PD‐1 expression on peripheral blood T‐cell subsets correlates with prognosis in non‐small cell lung cancer
    Kayoko Waki et al, 2014, Cancer Science CrossRef
26. Immunotherapy in pancreatic ductal adenocarcinoma: an emerging entity?
    I.H. Sahin et al, 2017, Annals of Oncology CrossRef
27. Immunotherapy for patients with advanced pancreatic carcinoma: a promising treatment
    Bin Zhang et al, 2017, Oncotarget CrossRef
28. Prospect and progress of personalized peptide vaccinations for advanced cancers
    Shinjiro Sakamoto et al, 2016, Expert Opinion on Biological Therapy CrossRef
29. Immunotherapy and pancreatic cancer: unique challenges and potential opportunities
    Kate Young et al, 2018, Therapeutic Advances in Medical Oncology CrossRef
30. Clinical Relevance of Antigen Spreading Pattern Induced by CHP-MAGE-A4 Cancer Vaccination
    Kengo Miyauchi et al, 2016, Immunotherapy CrossRef
31. Combination of 12-O-tetradecanoylphorbol-13-acetate with diethyldithiocarbamate markedly inhibits pancreatic cancer cell growth in 3D culture and in immunodeficient mice
    HUARONG HUANG et al, 2015, International Journal of Molecular Medicine CrossRef
32. Perspectives in the treatment of pancreatic adenocarcinoma
    Angel Cid-Arregui, 2015, World Journal of Gastroenterology CrossRef
33. Clinical Outcomes of Specific Immunotherapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis
    Jiang Chen et al, 2017, Journal of Immunology Research CrossRef
34. Integrity of circulating cell-free DNA as a prognostic biomarker for vaccine therapy in patients with nonsmall cell lung cancer
    Kayoko Waki et al, 2021, Immunopharmacology and Immunotoxicology CrossRef
35. CD4/CD8 ratio is a prognostic factor in IgG nonresponders among peptide vaccine‐treated ovarian cancer patients
    Kayoko Waki et al, 2020, Cancer Science CrossRef
36. Deploying Immunotherapy in Pancreatic Cancer: Defining Mechanisms of Response and Resistance
    Gregory L. Beatty et al, 2017, American Society of Clinical Oncology Educational Book CrossRef
37. Cancer stem cells: Involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics
    Cristiana Pistol Tanase, 2014, World Journal of Gastroenterology CrossRef
38. The clinical terrain of immunotherapies in heterogeneous pancreatic cancer: unravelling challenges and opportunities
    Melanie Herpels et al, 2023, The Journal of Pathology CrossRef
39. Development of tumour peptide vaccines: From universalization to personalization
    Minjun Ma et al, 2020, Scandinavian Journal of Immunology CrossRef
40. Systemic treatment of pancreatic cancer revisited
    Michel Ducreux et al, 2019, Seminars in Oncology CrossRef